Basil Leaf Extract and Eugenol against Isolates of Candida sp. Causing Oral Candidiasis in HIV/AIDS
DOI:
https://doi.org/10.66344/jpad.v32i4.2029Abstract
Background Oral candidiasis is an opportunistic infection of the oral mucosa caused by Candida sp., frequently found in HIV/AIDS patients. Basil leaf extract (Ocimum sanctum Linn.), which contains eugenol, a compound believed to inhibit the growth of Candida sp.
Objective To evaluate the antifungal effect of basil leaf extract (Ocimum sanctum Linn.) and eugenol compared to fluconazole against Candida sp. isolates.
Methods Basil leaf extract (Ocimum sanctum Linn.) with doses equivalent to eugenol 800 µg/mL and 400 µg/mL, eugenol doses at 800 µg/mL and 400 µg/mL, which was then compared with fluconazole 25 µg/mL against 40 Candida sp. isolated stored from the oral cavity of HIV/AIDS patients.
Results The average inhibition zone of fluconazole was 21.81 mm, the mean inhibition zone of eugenol with doses of 800 µg/mL and 400 µg/mL were 17.07 mm and 15.89 mm, and the mean inhibition zone of basil leaf extract (Ocimum sanctum Linn.) with doses equivalent to eugenol 800 µg/mL and 400 µg/mL were 14.87 mm and 14.01 mm (p = 0.001 and p < 0.05).
Conclusion Fluconazole had a significantly higher inhibition zone against Candida albicans and Candida non-albicans isolates than basil leaf extract (Ocimum sanctum Linn.) and eugenol.
References
1. Quindós G, Gil-Alonso S, Marcos-Arias C, Sevillano E, Mateo E, Jauregizar N, dan Eraso E. Therapeutic tools for oral candidiasis: Current and new antifungal drugs. Med Oral Patol Oral Cir Bucal. 2019;24(2):172-80.
2. Murtiastutik D, Maharani CS, Rahmadewi R, dan Listiawan MY. Nystatin profile on Candida species in HIV/AIDS patients with oral candidiasis: a phenomenology study. J Pure Appl Microbiol. 2019;13(4):2013-19.
3. Patil S, Majumdar B, Sarode SC, Sarode GS, dan Awan KH. Oropharyngeal candidosis in HIV-Infected patients—an update. Front Microbiol. 2018;1(1):1-9.
4. Kundu RV, dan Garg A. 2012. ‘Yeast Infections: Candidiasis, tinea (pityriasis) versicolor, and malassezia (pityrosporum) folliculitis’. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw Hill. 2298-301.
5. Lydiawati E, Listiawan MY, Murtiastutik D, Rahmadewi R, Prakoeswa CRS, Avanti C, Fitriani E, Astha ET, Astari L, dan Zulkarnain I. In vitro antifungal susceptibility testing of tea tree oil (TTO) 5% compared with nystatin against Candida sp. as important agent of oral candidiasis in HIV/AIDS patients. BIKKK. 2020;32(3): 189-94.
6. Rauseo AM, Coler-Reilly A, Larson L, dan Spec A. Hope on the horizon: novel fungal treatments in development. Open Forum Infect Dis. 2020;7(2):5-23.
7. Desmara S, Rezeki S, dan Sunnati S. Konsentrasi hambat minimum dan konsentrasi bunuh minimum ekstrak daun kemangi (O. sanctum L.) terhadap pertumbuhan Candida albicans. J Caninus Denst. 2017;2(1): 31-9.
8. De Ornay AK, Prehananto H, dan Dewi ASS. Growth inhibition of Candida albicans and power kill Candida albicans extract basil leave. Jurnal Wiyata. 2017;4(1):78-83.
9. Ahmad A, Khan A, dan Yousuf S. Proton translocating ATPase mediated fungicidal activity of eugenol and thymol. Fitoterapia. 2010;81(1):1157-62.
10. Godil AZ, Bhagat D, Das P, Kazi AI, Dugal, R, dan Satpute S. Fluconazole and Ocimum sanctum Oil in soft denture liners to treat biofilms of Candida albicans associated with denture stomatitis. Dentristry. 2021;9(1):1-11.
11. Khan A, Ahmad A, Khan LA, dan Manzoor N. Ocimum sanctum (L.) essential oil and its lead molecules induce apoptosis in Candida albicans. Res Microbiol. 2014;165(6):411-9.
12. Ghannoum M, Salem I, dan Christensen L. 2019. ‘Antifungals’. In: Kang, S., Amagai, M., Bruckner, A.L., Enk, A.H., Margolis, D.J., McMichael, A.J., Orringers, J.S., editors. Fitzpatrick’s dermatology. 9th ed. New York: McGraw Hill, 3436-45.
13. Sharifzadeh A, dan Shokri H. In vitro synergy of eugenol on the antifungal effects of voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares. Equine Vet J. 2020;3(1):94-101.
14. Brajawikalpa RS. dan Ramzy AN. Uji efektivitas antijamur minyak atsiri daun cengkeh (Syzygium aromaticum L.) terhadap pertumbuhan Malassezia furfur. Jurnal Kedokteran dan Kesehatan. 2018;4(1):49-51.
15. Silva ICG, Santos HBP, Cavalcanti YW, Nonaka CFW, Sousa SA, dan Castro RD. Antifungal activity of eugenol and its association with nystatin on Candida albicans. Pesquisa Brasileira em Odontopediatria e Clínica Integrada. 2017;17(1):1-8.
16. Jawetz, Melnick, dan Adelberg. 2007. ‘Mikrobiologi Kedokteran’. 23rd ed. Jakarta: ISBN 978-979- 448-859-1. 273-5.
17. Núñez IC, Arranz JC, Rivas CB, Mendonça PM, Perez K, Sánchez CD, Cortinhas LB, Silva CF, Carvalho M, dan Queiroz M. Chemical composition and toxicity of O. sanctum L. var. cubensis essential oil up-growing in the Eastern of Cuba. Phytopathology. 2017;9(7):1021-8.
18. De Paula SB, Bartelli TF, Di Raimo V, Santos JP, Morey AT, Bosini MA, Nakamura CV, Yamauchi LM, Yamada-Ogatta SF. Effect of eugenol on cell surface hydrophobicity, adhesion, and biofilm of Candida tropicalis and Candida dubliniensis isolated from oral cavity of HIV-Infected patients. Evid Based Complement Alternat Med. 2014;1(1):1-8.
19. Andayani A, Susilowati A, dan Pangastuti A. AntiCandida minyak atsiri lengkuas putih (Alpinia galanga) terhadap Candida albicans penyebab candidiasis secara invitro. El Vivo. 2014;2(2):1-9.
20. Jafri H, Banerjee G, dan Khan MSA. Synergistic interaction of eugenol and antimicrobial drugs in eradication of single and mixed biofilms of Candida albicans and Streptococcus mutans. AMB Expr. 2020;1(10):185.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Dwi Murtiastutik, Emma Hidayati Sasmito, Diah Mira Indramaya, Sawitri Sawitri, Rahmadewi Rahmadewi, Afif Nurul Hidayati, Pepy Dwi Endraswari, Sudjarwo Sudjarwo, Budi Utomo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
